Alpha Cognition (ACOG) Share-based Compensation (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Share-based Compensation came in at $355765.0 in Q4 2025, up 516.5% year-on-year from $57707.3 in Q4 2024, and down 60.36% quarter-over-quarter from $897581.0 in Q3 2025.
Alpha Cognition (ACOG) Share-based Compensation (2023 - 2025) Analysis & Trends
Alpha Cognition's Share-based Compensation history runs 3 years deep, the most recent figure standing at $355765.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation rose 516.5% year-over-year to $355765.0 in Q4 2025; TTM through Dec 2025 was $2.6 million, a 6.56% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, up 353.61% from the prior year.
- Share-based Compensation eased to $355765.0 in Q4 2025 per ACOG's latest filing, from $897581.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.3 million in Q1 2024 and bottomed at -$224299.0 in Q1 2025.
- The 3-year median for Share-based Compensation is $470156.0 (2023), against an average of $662883.2.
- Across the five-year window, Share-based Compensation tumbled 118.17% in 2024 and surged 516.5% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $470156.0 in 2023, then tumbled by 118.17% to -$85418.0 in 2024, then jumped by 516.5% to $355765.0 in 2025.
- Per Business Quant, the three latest ACOG Share-based Compensation figures stand at $355765.0 (Q4 2025), $897581.0 (Q3 2025), and $1.5 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | 355,765.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 355,765.00 |
| Dec 31, 2025 | 355,765.00 |
| Sep 30, 2025 | 897,581.00 |
| Sep 30, 2025 | 897,581.00 |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | -224,299.00 |
| Mar 31, 2025 | -224,299.00 |
| Dec 31, 2024 | -85,418.00 |
| Dec 31, 2024 | -85,418.00 |
| Sep 30, 2024 | 193,741.00 |
| Sep 30, 2024 | 193,741.00 |
| Jun 30, 2024 | 375,327.00 |
| Jun 30, 2024 | 375,327.00 |
| Mar 31, 2024 | 2.27 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 470,156.00 |
| Dec 31, 2023 | 470,156.00 |
| Sep 30, 2023 | 524,050.00 |
| Sep 30, 2023 | 524,050.00 |